KeyBanc analyst Aleksey Yefremov lowered the firm’s price target on Olin to $69 from $73 and keeps an Overweight rating on the shares. Olin acknowledged that an improvement in both chlor-alkali pricing and volumes is required to achieve the $1.3B EBITDA mark for this year, and while demand is believed to be moving in the right direction, the pace of recovery is slower than initially expected, the analyst says. The firm expects management to reduce guidance to the $1.1B-$1.2B range.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLN:
